|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016360,
umls-concept:C0021735,
umls-concept:C0027651,
umls-concept:C0034380,
umls-concept:C0038952,
umls-concept:C0205179,
umls-concept:C0348013,
umls-concept:C0574032,
umls-concept:C0871261,
umls-concept:C1527249,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1995-10-6
|
|
pubmed:abstractText |
The aim of this study was to investigate the effects of adding interferon alfa-2b (IFN) to protracted venous infusion fluorouracil (PVI 5-FU) from the start of treatment in patients with advanced colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2317-23
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7666089-Adolescent,
pubmed-meshheading:7666089-Adult,
pubmed-meshheading:7666089-Aged,
pubmed-meshheading:7666089-Alopecia,
pubmed-meshheading:7666089-Chi-Square Distribution,
pubmed-meshheading:7666089-Colorectal Neoplasms,
pubmed-meshheading:7666089-Combined Modality Therapy,
pubmed-meshheading:7666089-Disease-Free Survival,
pubmed-meshheading:7666089-Female,
pubmed-meshheading:7666089-Fluorouracil,
pubmed-meshheading:7666089-Humans,
pubmed-meshheading:7666089-Infusions, Intravenous,
pubmed-meshheading:7666089-Interferon-alpha,
pubmed-meshheading:7666089-Leukopenia,
pubmed-meshheading:7666089-Male,
pubmed-meshheading:7666089-Middle Aged,
pubmed-meshheading:7666089-Mouth Mucosa,
pubmed-meshheading:7666089-Prospective Studies,
pubmed-meshheading:7666089-Quality of Life,
pubmed-meshheading:7666089-Recombinant Proteins,
pubmed-meshheading:7666089-Remission Induction,
pubmed-meshheading:7666089-Stomatitis,
pubmed-meshheading:7666089-Survival Rate
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
|
|
pubmed:affiliation |
Cancer Research Campaign, Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
